We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.
Committee recommends COVID-19 vaccine for children with underlying medical conditions.
The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots.
First published during the 2019 to 2022 Johnson Conservative government
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the government on the use of COVID-19 vaccines to mitigate the impact of the B1.617.2 variant of concern.
The government's statement following updated advice from the Joint Committee on Vaccination and Immunisation (JCVI).
Information for immunisation practitioners and other health professionals.
Health and Social Care Secretary Sajid Javid accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) on Wednesday 22 December 2021.
The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).